>>5472

>So, you buy some add a few drops to a fresh gallon of milk and re-cap the milk. set it out at room temp or slightly warmer for 24 ~ 36 hours for the bacteria to reproduce. At this point (before it starts to curdle from the bacteria running out of food and dieing off) it still tastes OK so, you put it in the refridgerator to halt reproduction before the die off and it curdles and gets bitter. Then you drink a glass twice a day. Its that simple.

Anon, can you specify more about that?

How many drops?

Would it help if I made yogurt out of that?

Or would it be fine to do it with milk?

It raw milk okay for this?

Do I have to heat the milk up to kill the bacteria that is in there before putting 17938 in it?

>>19550

Ok, so let me repeat that:

1) Get raw milk

2) Heat it up so that the bacteria dies (how long? how far heat it up?)

3) Let it cool down to room temperature (refrigerator?)

4) Put in 17938 (how many drops?)

5) Keep it at room temperature for one to 1.5 days

6) Cool it down in a refrigerator

7) Drink it

8) Rinse and repeat for a few weeks

I will try to do that, and will document every step.

Did you try it yourself already?

>this works by seriously overwhelming your gut with this beneficial bacteria and killing off all the bad ones

Yes, that totally makes sense.

I read an official treatment report from 2 years ago and that even states that nutrition would be irrelevant to UC/CD. It's completely ridiculous. And it's known that certain bacteria causes it. You can starve them by avoiding certain sugars, but that only helps so much (even that isn't even mentioned in that report).

>>19551

Plus you sure about 1 day at room temperature?

I would have to keep it somewhere safe so that germs won't get into it.

Maybe I will even start keeping it for 6 hours at room temperature at first.

>>19566

Back

I'm trying this for a week now and I'm getting better at it.

My equipment is only capable of processing 1 liter of milk (around 25% of a gallon), and I used 12 drops and set the timer to 16-17 hours.

Mathwise it seems around 13 hours should do it at 38°C maybe even slighly less than that, but I'm not sure.

It's quite weird, I had 1 or 2 batches that smelled horribly and I threw those away. At other times I produced yoghurt successfully, it tastes … weird. Not really bad, but also not tasty. Combined with fruit it tastes fine.

Do you think 1 liter per day should be enough?

I could even try to do 2 batches per day at around 14 hours each.

>>24020

To add to this, there was a trial in 2012, but they used way too few.

https://pubmed.ncbi.nlm.nih.gov/22150569/

https://archive.is/aVXNm

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis

Methods: A total of 40 patients (median age: 7.2 years range 6-18) with mild to moderate UC were enrolled in a prospective, randomised, placebo-controlled study. They received an enema solution containing 10(10) CFU of L. reuteri ATCC 55730 or placebo for 8 weeks, in addition to oral mesalazine. Clinical endoscopic and histological scores as well as rectal mucosal expression levels of IL-10, IL-1β, TNFα and IL-8 were evaluated at the beginning and at the end of the trial.

Results: Thirty-one patients accomplished the trial (17 males, median age 13 year, range 7-18). Mayo score (including clinical and endoscopic features) decreased significantly in the L. reuteri group (3.2 ± 1.3 vs. 8.6 ± 0.8, P < 0.01) compared with placebo (7.1 ± 1.1 vs. 8.7 ± 0.7, NS); furthermore, histological score significantly decrease only in the L. reuteri group (0.6 ± 0.5 vs. 4.5 ± 0.6, P < 0.01) (placebo: 2.9 ± 0.8 vs. 4.6 ± 0.6, NS). At the post-trial evaluation of cytokine mucosal expression levels, IL-10 significantly increased (P < 0.01) whereas IL-1β, TNFα and IL-8 significantly decreased (P < 0.01) only in the L. reuteri group.

Conclusions: In children with active distal ulcerative colitis, rectal infusion of L. reuteri is effective in improving mucosal inflammation and changing mucosal expression levels of some cytokines involved in the mechanisms of inflammatory bowel disease.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318306/

Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)

Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) represents an emergent global threat which is straining worldwide healthcare capacity. As of May 27th, the disease caused by SARS-CoV-2 (COVID-19) has resulted in more than 340,000 deaths worldwide, with 100,000 deaths in the US alone. It is imperative to study and develop pharmacological treatments suitable for the prevention and treatment of COVID-19. Ascorbic acid is a crucial vitamin necessary for the correct functioning of the immune system. It plays a role in stress response and has shown promising results when administered to the critically ill. Quercetin is a well-known flavonoid whose antiviral properties have been investigated in numerous studies. There is evidence that vitamin C and quercetin co-administration exerts a synergistic antiviral action due to overlapping antiviral and immunomodulatory properties and the capacity of ascorbate to recycle quercetin, increasing its efficacy. Safe, cheap interventions which have a sound biological rationale should be prioritized for experimental use in the current context of a global health pandemic. We present the current evidence for the use of vitamin C and quercetin both for prophylaxis in high-risk populations and for the treatment of COVID-19 patients as an adjunct to promising pharmacological agents such as Remdesivir or convalescent plasma.

Proposed multi-drug approach for either the prophylaxis for high risk population, and treatment of mild and severe cases.

Quercetin Vitamin C

Prophylaxis 250–500 mg BID 500 mg BID

Mild cases 250–500 mg BID 500 mg BID

Severe Cases* 500 mg BID 3 gr q6 for 7 days

Conclusions

Quercetin displays a broad range of antiviral properties which can interfere at multiple steps of pathogen virulence -virus entry, virus replication, protein assembly- and that these therapeutic effects can be augmented by the co-administration of vitamin C. Furthermore, due to their lack of severe side effects and low-costs, we strongly suggest the combined administration of these two compounds for both the prophylaxis and the early treatment of respiratory tract infections, especially including COVID-19 patients.